Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.
about
Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesMechanisms of Autoantibody-Induced Pathology.Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG+ Memory B Cells.Analyzing pathogenic (double-stranded (ds) DNA-specific) plasma cells via immunofluorescence microscopy.Plasma cells as an innovative target in autoimmune disease with renal manifestations.Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.Maintenance of CD8(+) memory T lymphocytes in the spleen but not in the bone marrow is dependent on proliferation.Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.The chronically inflamed central nervous system provides niches for long-lived plasma cells.Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.Abnormal B-cell development in Systemic Lupus Erythematosus: what the genetics tell us.Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases.[Therapy-resistant cells of the B cell line].[Immunomodulatory therapy of autoimmune diseases : Quo vadis?].Targeting B Cells and Plasma Cells in Autoimmune Diseases.Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.
P2860
Q28074217-FEA91257-4E98-4E16-A609-2006A1319663Q33740580-587BFDE4-1ED1-4061-B2D2-549440B6D024Q35739625-AFF44D4D-1426-4B67-A9CA-DAC92AD71D32Q35972482-36ED7A8D-781B-415F-8705-389562E96412Q36202325-F2171E37-10DB-465A-8F42-2A872E7DAA40Q38753491-A115E695-51C6-4103-BC0B-641315ECDE46Q38979169-F86562D0-046F-4A30-A925-9843E191B4B7Q39303557-AB2A8D8E-0A14-4307-A3D3-7D8882CF3B68Q40090495-830693FB-6544-47A3-A973-0ED4D440CDBCQ40110864-EF57CEFB-584F-4984-B29D-4BE51A054975Q41363502-01236A27-70F0-49E2-9D95-96CF03781DCCQ47116115-D56113E1-6775-48EE-88C7-795C44512D1CQ47219879-84A13C36-064E-4CE2-8FAD-143365BCEFD0Q47365066-AD22A101-1114-4641-B7AF-E5DC2D5CECA3Q51152275-CFD3378D-F36A-4F16-8ED2-51C098478383Q52850241-B960519E-8FF9-4C02-9218-40FD73BD4B12Q52852647-7B796E39-75BF-4F5C-B2D7-CCF838B31AB1Q55234556-AE85EAC3-0258-4D1A-86C2-74E71F0540B1Q55266542-636E18CF-A7CA-4E0F-B81F-C7658640B49F
P2860
Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Long-lived plasma cells are ea ...... ma cells and their precursors.
@ast
Long-lived plasma cells are ea ...... ma cells and their precursors.
@en
type
label
Long-lived plasma cells are ea ...... ma cells and their precursors.
@ast
Long-lived plasma cells are ea ...... ma cells and their precursors.
@en
prefLabel
Long-lived plasma cells are ea ...... ma cells and their precursors.
@ast
Long-lived plasma cells are ea ...... ma cells and their precursors.
@en
P2093
P2860
P1476
Long-lived plasma cells are ea ...... ma cells and their precursors.
@en
P2093
Andreas Radbruch
Caroline Voigt
Falk Hiepe
Imtiaz M Mumtaz
Katrin Moser
Laleh Khodadadi
Qingyu Cheng
Rudolf A Manz
Tobias Alexander
P2860
P2888
P356
10.1186/S13075-015-0551-3
P577
2015-03-02T00:00:00Z
P5875
P6179
1044655085